CABALETTA BIO, INC. (CABA): Price and Financial Metrics
CABA Price/Volume Stats
| Current price | $2.18 | 52-week high | $13.50 |
| Prev. close | $2.21 | 52-week low | $0.99 |
| Day low | $2.04 | Volume | 1,568,800 |
| Day high | $2.27 | Avg. volume | 1,361,643 |
| 50-day MA | $1.45 | Dividend yield | N/A |
| 200-day MA | $2.82 | Market Cap | 110.62M |
CABA Stock Price Chart Interactive Chart >
CABALETTA BIO, INC. (CABA) Company Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
CABA Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CABA Price Returns
| 1-mo | 87.93% |
| 3-mo | 17.84% |
| 6-mo | -33.84% |
| 1-year | -80.22% |
| 3-year | 73.02% |
| 5-year | -74.26% |
| YTD | -3.96% |
| 2024 | -90.00% |
| 2023 | 145.41% |
| 2022 | 144.06% |
| 2021 | -69.63% |
| 2020 | -10.67% |